What must be submitted to the IRB and approved before advertising for a study can be used?

Approval from the Institutional Review Board (IRB) is crucial before any advertising for a study can take place because the advertisements must align with ethical standards and the study's protocol. The proposed advertising materials provide information about how the study will be presented to potential participants and must ensure that the information is accurate, not misleading, and complies with regulatory requirements.

These materials should clearly convey the nature of the study, what participation entails, and any potential risks or benefits involved. By reviewing and approving the proposed advertisements, the IRB ensures that recruitment processes protect the rights and well-being of potential participants and maintain the integrity of the research.

The other options, while important in the study process, do not specifically require prior IRB approval in the context of advertising. Study registration is typically done for transparency and accessibility but does not pertain directly to advertising content. Clinical trial results are usually published after the study is completed, and informed consent forms, although critical, are part of the research protocol that is reviewed but not specifically tied to the advertising process.